Limes Schlosskliniken AGFRA:LIK +1.92%32 EBITDA Margin % is 24.26% as of Dec. 2025, which is 52% above its 10-year median of 15.95. GuruFocus rates FRA:LIK with a GF Score™ of 32/100 and a GF Value™ of €476.57. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Limes Schlosskliniken AG ranks better than 86.23% on this metric.
Limes Schlosskliniken AG (FRA:LIK) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Limes Schlosskliniken AG EBITDA Margin % Related Terms
Limes Schlosskliniken AG EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LIK vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Limes Schlosskliniken AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Limes Schlosskliniken AG EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Limes Schlosskliniken AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Limes Schlosskliniken AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Limes Schlosskliniken AG (FRA:LIK) has a EBITDA Margin % of 24.26% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Limes Schlosskliniken AG and its competitors. This is 52% above median its historical median of 15.95. According to the industry distribution chart, Limes Schlosskliniken AG ranks #92 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Limes Schlosskliniken AG's EBITDA Margin % too high?
Limes Schlosskliniken AG's current EBITDA Margin % of 24.26% is 52% above median its 10-year median of 15.95. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Limes Schlosskliniken AG's value of 24.26% is 137.6% above this industry median. Based on the distribution chart, Limes Schlosskliniken AG ranks #92 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Limes Schlosskliniken AG has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Limes Schlosskliniken AG's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Limes Schlosskliniken AG ranks #92 out of 668 companies for EBITDA Margin %. This places Limes Schlosskliniken AG in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Limes Schlosskliniken AG's value of 24.26% is 137.6% above this benchmark. While the company's 10-year median is 15.95 vs. the industry median of 10.21, Limes Schlosskliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Limes Schlosskliniken AG's current EBITDA Margin % of 24.26% is 137.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Limes Schlosskliniken AG and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Limes Schlosskliniken AG's current EBITDA Margin % is 24.26%, which is 52% above median its own 10-year median of 15.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Limes Schlosskliniken AG stock overvalued right now?
Limes Schlosskliniken AG (FRA:LIK) has a current EBITDA Margin % of 24.26%. The stock's GF Value™ is €476.57, compared to a current price of €530.00 — trading 11.2% above its estimated fair value. The current EBITDA Margin % is 24.26%, which is 52% above median its 10-year median of 15.95 and 137.6% above the Healthcare Providers & Services industry median of 10.21. Limes Schlosskliniken AG's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Limes Schlosskliniken AG (FRA:LIK), the current EBITDA Margin % is 24.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Limes Schlosskliniken AG (FRA:LIK) Overvalued in 2026?
Based on GuruFocus' analysis, Limes Schlosskliniken AG stock appears to be overvalued.
The current stock price of €530.00 is trading 11.2% above its estimated GF Value™ of €476.57.
Key valuation signals for FRA:LIK:
EBITDA Margin %: 24.26% (52% above median its 10-year median of 15.95)
GF Value™: €476.57 vs. price of €530.00 (11.2% above fair value)
Industry Position: 137.6% above the Healthcare Providers & Services median (#92 of 668)
No single metric tells the full story. See the FRA:LIK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
32GF Score
Get the complete analysis for FRA:LIK
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LIK has been successfully added to your 
